Sensei Biotherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$34,101,000 over the previous period. Total operating expenses were $37,064,000.
Profit Margin
| 2018 | 0 | -13.03M | |
|---|---|---|---|
| 2019 | 0 | -18.99M | |
| 2020 | 0 | -20.62M | |
| 2021 | 0 | -37.46M | |
| 2022 | 0 | -48.80M | |
| 2023 | 0 | -34.10M |
SNSE Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 571K | 1.80M | 685K | 209K | 73K | 0 |
Gross profit | -571K | -1.80M | -685K | -209K | -73K | 0 |
Operating exp. | ||||||
Research and development | 18.29M | 30.38M | 21.66M | 11.18M | 8.35M | 8.22M |
Selling and marketing | 100K | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 37.06M | 50.18M | 37.48M | 18.71M | 12.43M | 12.74M |
Operating income | -37.06M | -50.18M | -37.48M | -19.45M | -12.43M | -12.74M |
Other income (expenses), net | 2.96M | 1.6M | 688K | -649K | -4.30M | 28K |
Income before tax | -34.10M | -48.58M | -36.79M | -20.1M | -16.74M | -13.03M |
Income tax expense | 0 | 219K | 670K | 529K | 2.25M | 299K |
Net income | -34.10M | -48.80M | -37.46M | -20.62M | -18.99M | -13.03M |
Earnings per share | ||||||
Basic EPS | -1.22 | -1.59 | -1.35 | -0.67 | -0.65 | -19.03 |
Diluted EPS | -1.22 | -1.59 | -1.35 | -0.67 | -0.65 | -19.03 |
| Data source | Data source | Data source | Data source |